潜伏性结核感染-话题@MedSci

#潜伏性结核感染#

8篇内容 | 848人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1523150, encodeId=28f5152315026, content=<a href='/topic/show?id=506a666808c' target=_blank style='color:#2F92EE;'>#潜伏性结核感染#</a>, objectTitle=Diabetes Care：潜伏性结核感染个体发生糖尿病的风险增加, objectType=article, longId=300031, objectId=de843000318a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de843000318a, replyNumber=0, likeNumber=31, createdTime=2022-03-05, rootId=0, userName=zhangxingru, userId=414111501439, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de843000318a, moduleTitle=Diabetes Care：潜伏性结核感染个体发生糖尿病的风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de843000318a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523149, encodeId=49a21523149a1, content=<a href='/topic/show?id=506a666808c' target=_blank style='color:#2F92EE;'>#潜伏性结核感染#</a>, objectTitle=J Infection：潜伏性结核感染会导致血清阳性 SARS-CoV-2 患者的炎症细胞因子水平升高, objectType=article, longId=217393, objectId=0e9421e393dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e9421e393dd, replyNumber=0, likeNumber=49, createdTime=2021-09-23, rootId=0, userName=zhangxingru, userId=414111501439, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e9421e393dd, moduleTitle=J Infection：潜伏性结核感染会导致血清阳性 SARS-CoV-2 患者的炎症细胞因子水平升高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e9421e393dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523148, encodeId=14251523148d8, content=<a href='/topic/show?id=506a666808c' target=_blank style='color:#2F92EE;'>#潜伏性结核感染#</a>, objectTitle=2020 NTAC/CDC建议：潜伏性结核感染的治疗指南, objectType=article, longId=188776, objectId=5e56188e764d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e56188e764d, replyNumber=0, likeNumber=26, createdTime=2020-02-27, rootId=0, userName=zhangxingru, userId=414111501439, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e56188e764d, moduleTitle=2020 NTAC/CDC建议：潜伏性结核感染的治疗指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e56188e764d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523147, encodeId=0613152314e17, content=<a href='/topic/show?id=506a666808c' target=_blank style='color:#2F92EE;'>#潜伏性结核感染#</a>, objectTitle=Eur Respir J：利福喷汀加异烟肼治疗中国潜伏性结核感染老年患者的短程疗效, objectType=article, longId=156386, objectId=258c1563861f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=258c1563861f, replyNumber=0, likeNumber=39, createdTime=2018-12-23, rootId=0, userName=zhangxingru, userId=414111501439, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=258c1563861f, moduleTitle=Eur Respir J：利福喷汀加异烟肼治疗中国潜伏性结核感染老年患者的短程疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=258c1563861f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523146, encodeId=9852152314697, content=<a href='/topic/show?id=506a666808c' target=_blank style='color:#2F92EE;'>#潜伏性结核感染#</a>, objectTitle=2016USPSTF建议声明——成人潜伏性结核感染的筛查发布, objectType=article, longId=77008, objectId=54c2e700899, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54c2e700899, replyNumber=0, likeNumber=0, createdTime=2016-09-10, rootId=0, userName=zhangxingru, userId=414111501439, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54c2e700899, moduleTitle=2016USPSTF建议声明——成人潜伏性结核感染的筛查发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54c2e700899)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523145, encodeId=1adf152314549, content=<a href='/topic/show?id=506a666808c' target=_blank style='color:#2F92EE;'>#潜伏性结核感染#</a>, objectTitle=专注结核60年：FDA批准赛诺菲结核病药物Priftin用于潜伏性结核感染（LTBI）治疗, objectType=article, longId=43578, objectId=1536435e836, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1536435e836, replyNumber=0, likeNumber=28, createdTime=2014-12-06, rootId=0, userName=zhangxingru, userId=414111501439, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1536435e836, moduleTitle=专注结核60年：FDA批准赛诺菲结核病药物Priftin用于潜伏性结核感染（LTBI）治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1536435e836)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523144, encodeId=23b0152314464, content=<a href='/topic/show?id=506a666808c' target=_blank style='color:#2F92EE;'>#潜伏性结核感染#</a>, objectTitle=AJRCCM：IFN-γELISPOT检测或不能有效评估潜伏性结核感染疗效, objectType=article, longId=23068, objectId=80a22306886, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80a22306886, replyNumber=0, likeNumber=43, createdTime=2013-08-21, rootId=0, userName=zhangxingru, userId=414111501439, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80a22306886, moduleTitle=AJRCCM：IFN-γELISPOT检测或不能有效评估潜伏性结核感染疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80a22306886)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523143, encodeId=83bf1523143b7, content=<a href='/topic/show?id=506a666808c' target=_blank style='color:#2F92EE;'>#潜伏性结核感染#</a>, objectTitle=AJRCCM：ELISPOT或非评估潜伏性结核感染疗效的合适方法, objectType=article, longId=22546, objectId=bd8d22546e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd8d22546e6, replyNumber=0, likeNumber=44, createdTime=2013-08-04, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd8d22546e6, moduleTitle=AJRCCM：ELISPOT或非评估潜伏性结核感染疗效的合适方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd8d22546e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

潜伏性结核感染

2020-05-29

zhangxingru (审核中...)

前往app查看评论内容

#潜伏性结核感染#

Diabetes Care：潜伏性结核感染个体发生糖尿病的风险增加

2022-03-05

zhangxingru (审核中...)

前往app查看评论内容

#潜伏性结核感染#

J Infection：潜伏性结核感染会导致血清阳性 SARS-CoV-2 患者的炎症细胞因子水平升高

2021-09-23

zhangxingru (审核中...)

前往app查看评论内容

#潜伏性结核感染#

2020 NTAC/CDC建议：潜伏性结核感染的治疗指南

2020-02-27

zhangxingru (审核中...)

前往app查看评论内容

#潜伏性结核感染#

Eur Respir J：利福喷汀加异烟肼治疗中国潜伏性结核感染老年患者的短程疗效

2018-12-23

zhangxingru (审核中...)

前往app查看评论内容

#潜伏性结核感染#

2016USPSTF建议声明——成人潜伏性结核感染的筛查发布

2016-09-10

zhangxingru (审核中...)

前往app查看评论内容

#潜伏性结核感染#

专注结核60年：FDA批准赛诺菲结核病药物Priftin用于潜伏性结核感染（LTBI）治疗

2014-12-06

zhangxingru (审核中...)

前往app查看评论内容

#潜伏性结核感染#

AJRCCM：IFN-γELISPOT检测或不能有效评估潜伏性结核感染疗效

2013-08-21

zhouqu_8 (审核中...)

前往app查看评论内容

#潜伏性结核感染#

AJRCCM：ELISPOT或非评估潜伏性结核感染疗效的合适方法

2013-08-04

科室
- - 订阅+
  - 更多科室
工具
服务